Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2018-2028

Global Vaccine Contract Manufacturing Market Report 2018-2028

Leading Countries, Technologies and Companies

PUBLISHED: 06 March 2018
PAGES: 150
PRODUCT CODE: PHA0292

Clear
WOOCS 2.2.1

The global vaccine contract manufacturing market was worth $883.0m in 2017 and is expected to grow at a CAGR of 9.1% from 2017-2022. Visiongain predicts a CAGR of 9.2% for the global vaccine contract manufacturing market over the whole forecast period (2017-2028).
 
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 150-page report you will receive 69 charts– all unavailable elsewhere.

The 150-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts to 2028 for the global vaccine market and market shares in 2017 and 2018 of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2028 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2028 for the leading national markets:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• Brazil
• Russia
• China
• India
• Rest of the World

Global Vaccine Contract Manufacturing Market Report 2018-2028

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridian Life Science
• Sigma Aldrich Fine Chemicals
• Merck
• Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market: Trends and SWOT Analysis

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2018-2028: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories